Stocks News Feed .com

Stock Market News

IPUT launches the Tropical Fruit Warehouse in Dublin’s Docklands

DUBLIN–(BUSINESS WIRE)–IPUT plc (“IPUT”) is pleased to launch the Tropical Fruit Warehouse, an 80,000 sq.ft. landmark office development on Sir John Rogerson’s Quay, Dublin 2 over-looking the Samuel Beckett bridge and River Liffey. 30-32 Sir John Rogerson’s Quay is the last remaining original warehouse on the quays and, from 1892, were used for the importation of tropical fruit into Ireland. The buildings are being redeveloped by IPUT as the Tropical Fruit Warehouse in recognition of this unique history. The transformative scheme, which has been designed by Henry J Lyons Architects in partnership with renowned façade specialists, Octatube, will deliver over 80,000 sq. ft. of uniq... »

Fountain Healthcare Partners Raises €118M for Third Fund

DUBLIN & NEW YORK–(BUSINESS WIRE)–Fountain Healthcare Partners (“Fountain”) today announces the initial closing of its third fund, Fountain Healthcare Partners Fund III, L.P. (“Fund III”) with €118 million of committed capital, exceeding its initial target raise of €100 million. Fund III is a dedicated life science venture capital (“VC”) fund and brings Fountain’s total capital under management to €294 million. Within the life science sector, Fund III will primarily focus on specialty pharmaceuticals, biotechnology and medical devices. Fountain will invest a majority of the capital in Fund III within Europe but expects to also make investments in the US market. Fund III is ex... »

Curetis Reports Positive Results from Clinical Validation Study for U.S. FDA 510(k) Submission of Unyvero LRT for BAL Samples

– Test shows overall weighted average sensitivity of 90.1% (94.7%) and overall weighted average specificity of 98.4% (97.9%) in prospective (retrospective) sample cohort – U.S. FDA 510(k) submission for Unyvero LRT BAL Application Cartridge in preparation Amsterdam, the Netherlands, and Holzgerlingen, Germany, May 23, 2019 — Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis”), a developer of next-level molecular diagnostic solutions, today announced key data from its successfully completed Unyvero LRT clinical performance evaluation study for BAL samples. The study was designed based on U.S. FDA feedback to demonstrate enhanced pe... »

TTS Pharma Limited Announces Closing of £10.3 Million Fundraising and New Board Appointment

The completion of series B fundraise of £10.3 million The appointment of Paul Atherton as Chairman COMPLETION OF SERIES B FUNDRAISE TTSPharma Limited (“TTS Pharma” or the “Company”), a UK company whichis a vertically integrated supply chain manager in the cultivation,manufacturing and development of the emerging ethical cannabis market,announces that it has successfully closed a private equity investmenttotalling £10.3 million, on the basis of a two-tranche investment. Thisinvestment will permit TTS Pharma to become one of the leading globalsuppliers in this fast-growing multibillion-dollar industry, by allowingit to expand its existing supply chain, develop its own f... »

FUJIFILM Doubles Down on Medium Format with the GFX 100; More Info at B&H

Photography News: FUJIFILM Announces GFX 100 Medium Format MirrorlessCamera B&H Photo would like to share the announcement of the FUJIFILMGFX 100 Medium Format Mirrorless Camera, a high-resolutionpowerhouse well-equipped for professional studio and street use. Thelatest flagship GFX effectively doubles the resolution of itspredecessor with a whopping 102MP 43.9mm x 32.9mm back-illuminatedimaging sensor. To maximize the benefits of the new sensor, the GFX 100also includes improved autofocusing capabilities, image stabilization,and an updated processing engine. Rounding out its functionality is theability to record in DCI and UHD 4K video up to 30 fps. First priority for the FujifilmGFX 10... »

Recent Activity